Literature DB >> 10469265

Tissue distribution of rat macroglobulins in tumour-bearing rats.

N V Maltseva1, R M Zorina, N V Mingaljev, N A Krajushkina, T S Chirikova, N A Zorin.   

Abstract

Rat macroglobulins were determined in blood sera and extracts of tissues of intact rats and rats with Walker carcinoma by rocket immunoelectrophoresis. The serum levels of alpha1-macroglobulin (alpha1MG) alpha2-macroglobulin (alpha2MG) and pregnancy-associated alpha1-glycoprotein (alpha1PAG) were 1.86 +/- 0.07 mg/ml, 0.12 +/- 0. 02 mg/ml and 18.32 +/- 4.07 AU/ml respectively in control rats. Maximum concentrations of alpha1MG were found in heart, lung and spleen and lesser quantities were in liver and thymus, while alpha2MG and alpha1PAG were not found at all in tissue extracts from control rats. Serum alpha2MG and alpha1PAG concentrations increased more than 30-fold in tumour-bearing rats compared to control animals, while alpha1MG serum concentration was little changed. Increases in all three macroglobulins occurred in the tissues of tumour-bearing rats, particularly alpha1PAG. The tissue concentrations of alpha1MG and alpha2MG were similar and the tissue distribution was also similar with highest concentrations in heart and lung. Considerable quantities of the proteins were found in the tumour and part of peritoneum which made contact with the tumour. Changes in the protein concentrations in serum and tissue extracts of tumour-bearing rats suggest that all members of rat macroglobulin family are disturbed during the development of the Walker carcinoma, though only alpha2MG and alpha1PAG were substantially elevated.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10469265      PMCID: PMC2517758          DOI: 10.1046/j.1365-2613.1999.00103.x

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  21 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Variation of the alpha 2-macroglobulin homologue with age in some mammals.

Authors:  P O Ganrot
Journal:  Scand J Clin Lab Invest       Date:  1968       Impact factor: 1.713

3.  2 -acute phase globulin in rat serum. Purification, determination and interaction with trypsin.

Authors:  K Ganrot
Journal:  Biochim Biophys Acta       Date:  1973-01-25

4.  Studies on the immunosuppressive properties of a pregnancy-associated alpha-macroglobulin.

Authors:  W H Stimson
Journal:  Clin Exp Immunol       Date:  1976-08       Impact factor: 4.330

5.  Association between rat serum alpha-macroglobulins and splenic macrophages.

Authors:  C H Horne; E S Gray; G B Scott; G D Milne
Journal:  Experientia       Date:  1975-03-15

6.  Pregnancy-associated alpha 2 glycoprotein (alpha 2 PAG) synthesis by human breast cancer tissue and cultured cell lines.

Authors:  E J Sarcione; D Delluomo; M Zloty
Journal:  Int J Cancer       Date:  1983-02-15       Impact factor: 7.396

7.  Demonstration of pregnancy-associated alpha 2-glycoprotein (alpha 2-PAG) in pregnant, estrogen-treated and breast cancer-bearing rats.

Authors:  E J Sarcione; D S Delluomo
Journal:  Oncodev Biol Med       Date:  1981

8.  Demonstration of serum alpha1-macroglobulin on leucocyte surfaces in non-pregnant and pregnant rats.

Authors:  A W Thomson; F K Wong; C H Horne
Journal:  Invest Cell Pathol       Date:  1980 Jul-Sep

9.  Comparison of synthesis and secretion of plasma albumin, fibrinogen and alpha 2-macroglobulin by slices of Morris hepatomas and rat liver.

Authors:  A Koj
Journal:  Br J Exp Pathol       Date:  1980-06

10.  Correlation of the blood-level of a pregnancy-associated alpha-macroglobulin with the clinical course of cancer patients.

Authors:  W H Stimson
Journal:  Lancet       Date:  1975-04-05       Impact factor: 79.321

View more
  1 in total

1.  The common heat shock protein receptor CD91 is up-regulated on monocytes of advanced melanoma slow progressors.

Authors:  J Stebbing; M Bower; B Gazzard; A Wildfire; H Pandha; A Dalgleish; J Spicer
Journal:  Clin Exp Immunol       Date:  2004-11       Impact factor: 4.330

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.